p. 737 Impact of reference-based pricing for angiotensin-converting enzyme inhibitors on drug utilization
— S. Schneeweiss et al
p. 763 Why is calling an ACE an ACE so controversial? Evaluating reference-based pricing in British Columbia
— A. Anis
Canadian Medical Association Journal